25 September 2019: Development of a Fully Automated Measurement Method for Soluble Immune Checkpoint Molecules (sPD-1, sPD-L1 and sCTLA-4)

Sysmex Corporation (HQ: Kobe, Japan; Chairman & CEO: Hisashi Ietsugu) and Kyoto University (Sakyo-ku, Kyoto, Japan; President: Juichi Yamagiwa) announce the development of a fully automated measurement method for soluble immune checkpoint molecules (sPD-1, sPD-L1 and sCTLA-4) through joint R&D conducted since 2013 by Sysmex and Tasuku Honjo, a distinguished professor at the Kyoto University Institute for Advanced Studies. The two parties will proactively conduct clinical research using this measurement method to create new diagnostic technologies for cancer and immune disease.

17 September 2019: Sysmex Selected for Inclusion in the Dow Jones Sustainability World Index for the Fourth Consecutive Year

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) announces that it has been selected for inclusion in the Dow Jones Sustainability World Index (DJSI World), a leading global index of ESG investment, for the fourth consecutive year.

03 September 2019: Japan’s First Automated Hematology Analyzer Registered by the National Museum of Nature and Science as “Essential Historical Material for Science and Technology”

Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) announces that the CC-1001 automated hematology analyzer, which the Company developed as Japan’s first instrument for automatically measuring the number of red and white blood cells, has been registered by Japan’s National Museum of Nature and Science (Director General: Yoshihiro Hayashi) as “Essential Historical Material for Science and Technology”, also known colloquially as “MIRAI Technology Heritage.”